277 related articles for article (PubMed ID: 38619448)
1. Alpha-fetoprotein: Past, present, and future.
Yeo YH; Lee YT; Tseng HR; Zhu Y; You S; Agopian VG; Yang JD
Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38619448
[TBL] [Abstract][Full Text] [Related]
2. Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma.
Zheng Y; Zhu M; Li M
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2439-2446. PubMed ID: 32725355
[TBL] [Abstract][Full Text] [Related]
3. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
[No Abstract] [Full Text] [Related]
4. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
[TBL] [Abstract][Full Text] [Related]
5. Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng-Tongji cohort study.
Wang K; Bai Y; Chen S; Huang J; Yuan J; Chen W; Yao P; Miao X; Wang Y; Liang Y; Zhang X; He M; Yang H; Guo H; Wei S
Cancer Med; 2018 Jun; 7(6):2691-2698. PubMed ID: 29696820
[TBL] [Abstract][Full Text] [Related]
6. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM
PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma.
Song P; Tang Q; Feng X; Tang W
Scand J Clin Lab Invest Suppl; 2016; 245():S70-6. PubMed ID: 27438343
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
9. α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study.
Lu SX; Huang YH; Liu LL; Zhang CZ; Yang X; Yang YZ; Shao CK; Li JM; Xie D; Zhang X; Jain D; Yun JP
Br J Cancer; 2021 Jun; 124(12):1988-1996. PubMed ID: 33824478
[TBL] [Abstract][Full Text] [Related]
10. Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma.
Kong SY; Park JW; Kim JO; Lee NO; Lee JA; Park KW; Hong EK; Kim CM
J Cancer Res Clin Oncol; 2009 Aug; 135(8):1091-8. PubMed ID: 19184104
[TBL] [Abstract][Full Text] [Related]
11. The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients.
Xu F; Zhang L; He W; Song D; Ji X; Shao J
Dis Markers; 2021; 2021():8868370. PubMed ID: 33628341
[TBL] [Abstract][Full Text] [Related]
12. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage.
Luo P; Wu S; Yu Y; Ming X; Li S; Zuo X; Tu J
Pathol Oncol Res; 2020 Apr; 26(2):599-603. PubMed ID: 30661224
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X
Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272
[TBL] [Abstract][Full Text] [Related]
14. Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma.
Zhan Z; Guan Y; Mew K; Zeng W; Peng M; Hu P; Yang Y; Lu Y; Ren H
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G305-G312. PubMed ID: 31736338
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma.
Fatima S; Luk JM; Poon RT; Lee NP
Expert Rev Mol Diagn; 2014 Jun; 14(5):535-48. PubMed ID: 24809435
[TBL] [Abstract][Full Text] [Related]
16. Racial disparities in alpha-fetoprotein testing and alpha-fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients.
Wu G; Wu J; Pan X; Liu B; Yao Z; Guo Y; Shi X; Ding Y
Cancer Med; 2019 Nov; 8(15):6614-6623. PubMed ID: 31517445
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
18. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
19. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Yao M; Zhao J; Lu F
Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
[TBL] [Abstract][Full Text] [Related]
20. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
Feng H; Li B; Li Z; Wei Q; Ren L
BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
